SPARC and neoplasm: The expression of THY1 is up-regulated in GC tissues, where it could potentially inhibit the apoptosis of GC cells by regulating the level of SPARC protein, and CD90+(THY1) cells that have a greater potential to initiate tumor formation as well as the process of self-renewal in vivo [11].